Medivir – Interim Report, January – March 2016

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:

Medivir AB (STO:MVIRB)

Financial summary for the first quarter

· Net turnover totalled SEK 75.0 million (215.9 m), of which SEK 18.1 million (128.6 m) comprised royalties for simeprevir.